TB Notes Newsletter
No. 1, 2007
QuantiFERON-TB Gold Education: Responding to the National Need
On June 26, 2006, the four Regional Training and Medical Consultation
Centers (RTMCCs) joined forces to present a Web-based seminar entitled
QuantiFERON-TB Gold – Putting New Technologies into Practice.
This national educational offering attracted an estimated 800 participants.
Some took part individually while others attended as a group, listening
together in conference rooms. The seminar was funded by Cellestis,
the company that developed QuantiFERON-TB Gold, through an unrestricted
The RTMCCs used the systematic health education process to develop
this Web-based program. The combined RTMCC’s national needs
assessment data about the desirability of the topic and the use
and ability to access Web-based technology were key to the planning
process. Next, the faculty members were tapped for thoughts and
ideas. Finally, the program was evaluated to assess the impact of
its content and format. The Southeastern National Tuberculosis Center
facilitated the provision of continuing education credits for physicians,
nurses, and health educators to increase marketability of the program.
The RTMCCs marketed the program to its standard select audiences,
while Cellestis was instrumental in reaching nontraditional audiences
such as community-based providers and laboratory personnel, who
may not normally be a part of RTMCC courses.
The seminar featured presentations on the science behind QuantiFERON-TB
Gold, a summary of the CDC guidelines, and practical uses of the
test in the field. Most participants were nurses, followed by lab
staff and physicians. Presenters included Dr. Alfred Lardizabal
from the Northeastern RTMCC, Dr. Phil Lobue from the Division of
TB Elimination at CDC, and Dr. Masae Kawamura from the Francis J.
Curry National Tuberculosis Center. The program was moderated by
Dr. David Lakey from the Heartland National Tuberculosis Center.
Attendees benefited from the RTMCCs’ expertise in innovative
science and technology, not to mention their experience in providing
training to others. There was a question-and-answer session at the
end of the program, and the Web-based format allowed for questions
throughout the program to be sent electronically to the presenters.
Participants were interested not only in how QuantiFERON-TB Gold
works, but also in its practical applications. Written and verbal
questions ranged from the sensitivity and specificity of the test
to how it can be accessed by TB control programs. There was a demonstrated
eagerness to learn more and hear about the future of diagnosing
latent TB infection.
The course was evaluated via the Internet-based survey service,
Zoomerang,® set up by the Southeastern National Tuberculosis
Center. There were 435 responses to the evaluation. The conference
was well rated in terms of the knowledge of the speakers, the practical
uses of the information, and the method of providing education via
the Web. There were comments about the need for the slides; hence,
we are providing them to readers: QuantiFERON-TB
Gold – Putting New Technologies into Practice - archived
presentation and copies of the presenters’ slides.
—Submitted by Rajita
Northeastern Regional Training and Medical Consultation Consortium
Francis J. Curry National Tuberculosis Center
Southeastern National Tuberculosis Center
Heartland National Tuberculosis Center
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333